4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-010602
PRINCIPAL ACCOUNTING OFFICER sold 1,790 shares at $17.87 ($31,987)
- PRINCIPAL ACCOUNTING OFFICER acquired 3,499 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2024-04-05 | Option exercise | +2,010 | 13,401 | D | ||
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2024-04-07 | Option exercise | +1,489 | 14,890 | D | ||
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2024-04-08 | Sale | −1,028 | $17.87 | $18,370 | 13,862 | D |
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2024-04-08 | Sale | −762 | $17.87 | $13,617 | 13,100 | D |
| Derivatives | |||||||
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2024-04-05 | Option exercise · Restricted Stock Units | −2,010 | 4,020 | D | ||
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2024-04-07 | Option exercise · Restricted Stock Units | −1,489 | 0 | D | ||
| Open-market sales · 1,790 sh · avg $17.87 · $31,987 | |||||||
Loading xslF345X05/form4-04092024_060403.xml…